Mineralys Therapeutics’ $40 Million Series A Funding Round

Latham & Watkins LLP represented Mineralys Therapeutics, Inc. in the transaction.Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific, completed a US$40 million…